| This article has been cited by | | 1 | A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit | | | Pierre-François Laterre,Miguel Sánchez-García,Tom van der Poll,Olga de la Rosa,Kathy-Ann Cadogan,Eleuterio Lombardo,Bruno François | | BMC Pulmonary Medicine.2020;20(1) | | [DOI] | |
|
|
|
